Cargando…

Altered Calcium Homeostasis Does Not Explain the Contractile Deficit of Diabetic Cardiomyopathy

OBJECTIVE—This study examines the extent to which the contractile deficit of diabetic cardiomyopathy is due to altered Ca(2+) homeostasis. RESEARCH DESIGN AND METHODS—Measurements of isometric force and intracellular calcium ([Ca(2+)](i), using fura-2/AM) were made in left ventricular (LV) trabecula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Lin, Cannell, Mark B., Phillips, Anthony R.J., Cooper, Garth J.S., Ward, Marie-Louise
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2008
Materias:	Pathophysiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2494698/ https://www.ncbi.nlm.nih.gov/pubmed/18492789 http://dx.doi.org/10.2337/db08-0140

Ejemplares similares

Pericyte Bridges in Homeostasis and Hyperglycemia
por: Corliss, Bruce A., et al.
Publicado: (2020)

Hypothalamic Vitamin D Improves Glucose Homeostasis and Reduces Weight
por: Sisley, Stephanie R., et al.
Publicado: (2016)

Protection of the heart by treatment with a divalent-copper-selective chelator reveals a novel mechanism underlying cardiomyopathy in diabetic rats
por: Zhang, Lin, et al.
Publicado: (2013)

SGLT2 Deletion Improves Glucose Homeostasis and Preserves Pancreatic β-Cell Function
por: Jurczak, Michael J., et al.
Publicado: (2011)

Metrnl Alleviates Lipid Accumulation by Modulating Mitochondrial Homeostasis in Diabetic Nephropathy
por: Zhou, Yuxia, et al.
Publicado: (2023)

Protein Engineering Strategies for Sustained Glucagon-Like Peptide-1 Receptor–Dependent Control of Glucose Homeostasis
por: Picha, Kristen M., et al.
Publicado: (2008)

TRB3 Gene Silencing Alleviates Diabetic Cardiomyopathy in a Type 2 Diabetic Rat Model
por: Ti, Yun, et al.
Publicado: (2011)

GIP Does Not Potentiate the Antidiabetic Effects of GLP-1 in Hyperglycemic Patients With Type 2 Diabetes
por: Mentis, Nikolaos, et al.
Publicado: (2011)

Early Treatment of NOD Mice With B7-H4 Reduces the Incidence of Autoimmune Diabetes
por: Wang, Xiaojie, et al.
Publicado: (2011)

Circulating C-Peptide Levels in Living Children and Young People and Pancreatic β-Cell Loss in Pancreas Donors Across Type 1 Diabetes Disease Duration
por: Carr, Alice L.J., et al.
Publicado: (2022)

Expression of Human Chemerin Induces Insulin Resistance in the Skeletal Muscle but Does Not Affect Weight, Lipid Levels, and Atherosclerosis in LDL Receptor Knockout Mice on High-Fat Diet
por: Becker, Melanie, et al.
Publicado: (2010)

High Glucose Inhibits the Aspirin-Induced Activation of the Nitric Oxide/cGMP/cGMP-Dependent Protein Kinase Pathway and Does Not Affect the Aspirin-Induced Inhibition of Thromboxane Synthesis in Human Platelets
por: Russo, Isabella, et al.
Publicado: (2012)

Alterations in Lipid Signaling Underlie Lipodystrophy Secondary to AGPAT2 Mutations
por: Subauste, Angela R., et al.
Publicado: (2012)

Altered Skeletal Muscle Lipase Expression and Activity Contribute to Insulin Resistance in Humans
por: Badin, Pierre-Marie, et al.
Publicado: (2011)

A role of the adaptive immune system in glucose homeostasis
por: Bronsart, Laura L, et al.
Publicado: (2016)

Muscle-Specific Vascular Endothelial Growth Factor Deletion Induces Muscle Capillary Rarefaction Creating Muscle Insulin Resistance
por: Bonner, Jeffrey S., et al.
Publicado: (2013)

Genetic Defects in Human Pericentrin Are Associated With Severe Insulin Resistance and Diabetes
por: Huang-Doran, Isabel, et al.
Publicado: (2011)

TNF-α Signals Through PKCζ/NF-κB to Alter the Tight Junction Complex and Increase Retinal Endothelial Cell Permeability
por: Aveleira, Célia A., et al.
Publicado: (2010)

Increased Cytochrome P4502E1 Expression and Altered Hydroxyeicosatetraenoic Acid Formation Mediate Diabetic Vascular Dysfunction: Rescue by Guanylyl-Cyclase Activation
por: Schäfer, Andreas, et al.
Publicado: (2010)

FTO Is Increased in Muscle During Type 2 Diabetes, and Its Overexpression in Myotubes Alters Insulin Signaling, Enhances Lipogenesis and ROS Production, and Induces Mitochondrial Dysfunction
por: Bravard, Amélie, et al.
Publicado: (2011)

A Critical Role for Thioredoxin-Interacting Protein in Diabetes-Related Impairment of Angiogenesis
por: Dunn, Louise L., et al.
Publicado: (2014)

Coexistent Diabetes Is Associated With the Presence of Adverse Phenotypic Features in Patients With Hypertrophic Cardiomyopathy
por: Jex, Nicholas, et al.
Publicado: (2022)

Rapid Tachyphylaxis of the Glucagon-Like Peptide 1–Induced Deceleration of Gastric Emptying in Humans
por: Nauck, Michael A., et al.
Publicado: (2011)

IGF-I Bioactivity in an Elderly Population: Relation to Insulin Sensitivity, Insulin Levels, and the Metabolic Syndrome
por: Brugts, Michael P., et al.
Publicado: (2010)

The Glucagonostatic and Insulinotropic Effects of Glucagon-Like Peptide 1 Contribute Equally to Its Glucose-Lowering Action
por: Hare, Kristine J., et al.
Publicado: (2010)

Evidence for impaired chronotropic responses to and recovery from 6‐minute walk test in women with post‐acute COVID‐19 syndrome
por: Baranauskas, Marissa N., et al.
Publicado: (2021)

Diabetic Retinopathy and Cognitive Decline in Older People With Type 2 Diabetes: The Edinburgh Type 2 Diabetes Study
por: Ding, Jie, et al.
Publicado: (2010)

Deficits in systemic biomarkers of neuroinflammation and growth factors promoting nerve regeneration in patients with type 2 diabetes and polyneuropathy
por: Ziegler, Dan, et al.
Publicado: (2019)

Soluble RAGE Prevents Type 1 Diabetes Expanding Functional Regulatory T Cells
por: Leung, Sherman S., et al.
Publicado: (2022)

Loss of Inverse Relationship Between Pulsatile Insulin and Glucagon Secretion in Patients With Type 2 Diabetes
por: Menge, Björn A., et al.
Publicado: (2011)

Glucagon-Like Peptide 1 Receptor Activation Augments Cardiac Output and Improves Cardiac Efficiency in Obese Swine After Myocardial Infarction
por: Sassoon, Daniel J., et al.
Publicado: (2017)

Glucagon-Like Peptide 1 Recruits Muscle Microvasculature and Improves Insulin’s Metabolic Action in the Presence of Insulin Resistance
por: Chai, Weidong, et al.
Publicado: (2014)

Effects of the Selective Serotonin Reuptake Inhibitor Fluoxetine on Counterregulatory Responses to Hypoglycemia in Individuals With Type 1 Diabetes
por: Briscoe, Vanessa J., et al.
Publicado: (2008)

NOX2 Deficiency Protects Against Streptozotocin-Induced β-Cell Destruction and Development of Diabetes in Mice
por: Xiang, Fu-Li, et al.
Publicado: (2010)

Cellular Stress, Excessive Apoptosis, and the Effect of Metformin in a Mouse Model of Type 2 Diabetic Embryopathy
por: Wu, Yanqing, et al.
Publicado: (2015)

Effects of a Selective Serotonin Reuptake Inhibitor, Fluoxetine, on Counterregulatory Responses to Hypoglycemia in Healthy Individuals
por: Briscoe, Vanessa J., et al.
Publicado: (2008)

Effects of Intensive Therapy and Antecedent Hypoglycemia on Counterregulatory Responses to Hypoglycemia in Type 2 Diabetes
por: Davis, Stephen N., et al.
Publicado: (2009)

A network analysis to identify pathophysiological pathways distinguishing ischaemic from non‐ischaemic heart failure
por: Sama, Iziah E., et al.
Publicado: (2020)

Diabetes, Abdominal Adiposity, and Atherogenic Dyslipoproteinemia in Women Compared With Men
por: Williams, Ken, et al.
Publicado: (2008)

Plasma proteomic approach in patients with heart failure: insights into pathogenesis of disease progression and potential novel treatment targets
por: Cao, Thong H., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_akgkeqg2cms878h33ut4lppifc